Company intelligence / Profile preview

Enzychem Lifesciences

Seoul, Seoul, South Koreaenzychem.com ↗

Ownership: Private
Employees: ~122
Development stage: Phase 2

Overview

Enzychem’s lead candidate EC‑18 has completed Phase II studies for chemoradiation-induced oral mucositis and has shown safety/tolerability. The company also has ongoing or planned trials in chemotherapy-induced neutropenia, acute radiation syndrome, COVID‑19–related ARDS, NASH, and immune checkpoint inhibitor-related toxicities. Fast Track Designation was granted by the US FDA for CRIOM; Orphan Drug Designation was granted for ARS. Preclinical data support anti-inflammatory effects across several disease models.[1][2][6]

Therapeutic areas: GastroenterologyImmunologyOncologyRare DiseasesInfectious Diseases
Modalities: Small molecules
Industry: Biotech

Drug pipeline

3 assets

mosedipimod

2 more assets in the full pipeline.

Request access →

Partnerships

National Institutes of Health/NIAID CCRP collaboration on CERF program; potential BARDA funding for ARS program[6][7].

Beyond the preview

Go deeper on Enzychem Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzychem Lifesciences.

Explore the full profile